Showing 21,301 - 21,320 results of 49,222 for search '(( 5 ((point decrease) OR (mean decrease)) ) OR ( 50 ((teer decrease) OR (a decrease)) ))', query time: 0.88s Refine Results
  1. 21301

    Supplementary file 1_Exposure-response analyses of venetoclax combined with hypomethylating agents in myelodysplastic syndromes: a retrospective study.docx by Ji-Xin Tian (21710993)

    Published 2025
    “…Compared to VEN 400 mg administered without azole antifungals, concomitant use of azole antifungals with VEN 100 mg resulted in a 100.03% and 18.50% increase in VEN C<sub>0</sub> and C<sub>6</sub>, respectively. …”
  2. 21302

    A 12-Week Exercise Program for Pregnant Women with Obesity to Improve Physical Activity Levels: An Open Randomised Preliminary Study by Michèle Bisson (796416)

    Published 2015
    “…Analyses were performed using repeated measures ANOVA.</p><p>Results</p><p>A total of fifty (50) women were randomised, 25 in each group. …”
  3. 21303

    Supplementary Material for: Immunosuppressant Agents as Add-On Therapy Failed to Improve the Outcome of Immunoglobulin A Nephropathy with Crescent Score C1 by Bi X. (18245797)

    Published 2024
    “…Conversely, IgAN patients with C1 lesions and a cellular crescent ratio exceeding 50% treated with CS and immunosuppressant therapy experienced a significant improvement in renal function and a decline in urinary protein creatinine ratio. …”
  4. 21304
  5. 21305
  6. 21306
  7. 21307
  8. 21308
  9. 21309
  10. 21310
  11. 21311

    Supplementary Material for: The Effect of Peroral Endoscopic Myotomy in Achalasia Patients with Prior Endoscopic Intervention: A Systematic Review and Meta-Analysis by Zhong C. (3931220)

    Published 2021
    “…In the PFI group, the pooled estimated rate of technical success was 97.7% (95% confidence interval [CI], 95.8–98.8%), the pooled clinical success rate was 91.0% (95% CI, 88.0–93.4%), and the pooled adverse events rate was 23.5% (95% CI, 10.6–44.1%). The Eckardt score significantly decreased by 5.95 points (95% CI, 5.50–6.40, <i>p</i> < 0.00001) and the LES pressure significantly reduced by 19.74 mm Hg (95% CI, 14.10–25.39, <i>p</i> < 0.00001) in the PFI group. …”
  12. 21312

    Cox proportional hazard ratios. by Bryan S. Margulies (21492667)

    Published 2025
    “…Nevertheless, it is notable that the positive effects of MBC-005 treatment on increasing survival and decreasing tumor volume in mice was achieved using a single dose.…”
  13. 21313

    Bioluminescent Doubling Time. by Bryan S. Margulies (21492667)

    Published 2025
    “…Nevertheless, it is notable that the positive effects of MBC-005 treatment on increasing survival and decreasing tumor volume in mice was achieved using a single dose.…”
  14. 21314

    Study Design. by Bryan S. Margulies (21492667)

    Published 2025
    “…Nevertheless, it is notable that the positive effects of MBC-005 treatment on increasing survival and decreasing tumor volume in mice was achieved using a single dose.…”
  15. 21315

    Experimental disagreement between MCC and <i>Kappa</i> for <i>M</i><sub>4</sub>(<i>A</i>). by Rosario Delgado (6204512)

    Published 2019
    “…<p>Entropy decreases to zero, which implies that asymmetry increases, for <i>A</i> increasing from 50 to 100, and from <i>A</i> decreasing from 50 to 0, by symmetry.…”
  16. 21316
  17. 21317
  18. 21318
  19. 21319

    Data_Sheet_1_Microplastic Monitoring at Different Stages in a Wastewater Treatment Plant Using Reflectance Micro-FTIR Imaging.PDF by Alexander S. Tagg (9133388)

    Published 2020
    “…Despite the marked reduction in the number of MP particles following the primary settlement stage, an average total of 1.5 MP L<sup>–1</sup> were identified in the final effluent of the WWTP.…”
  20. 21320

    Association of interleukin-6 with sarcopenia and its components in older adults: a systematic review and meta-analysis of cross-sectional studies by Jie Ding (73711)

    Published 2024
    “…</p> <p>This meta-analysis establishes a link between increased serum IL-6 levels and sarcopenia in the elderly, particularly in relation to decreased muscle mass.…”